Benzinga | Aug 18, 2021 11:04AM EDT

Smallest Heart Pump From Abiomed Gets FDA Breakthrough Device Tag

* The FDA has granted breakthrough device designation to Abiomed Inc's (NASDAQ:ABMD) Impella ECP expandable percutaneous heart pump.

* Abiomed designed the Impella ECP heart pump to be compatible with small-bore access and closure techniques. It measures 3 mm in diameter when inserted and removed from the body.

* It expands in the heart to support its pumping function and provides a flow greater than 3.5 L/min.

* Abiomed's breakthrough device designation follows the FDA's premarket approval of its Impella RP right heart pump in June.

* Related content: Benzinga's Full FDA Calendar.

* Price Action: ABMD shares are up 1.34% at $332.97 during the market session on the last check Wednesday.